Predictor | All patients (n = 75) | Non-HBS (n = 43) | HBS (n = 32) | Statistic | P value |
---|---|---|---|---|---|
Gender (male/female) |  |  |  | χ2 = 0.288 | 0.592 |
 Male | 49 (65.3%) | 27 (62.8%) | 22 (68.8%) |  |  |
 Female | 26 (34.7%) | 16 (37.2%) | 10 (31.3%) |  |  |
Dialysis modality |  |  |  | χ2 < 0.001 | 1.000 |
 Hemodialysis | 73 (97.3%) | 42 (97.7%) | 31 (96.9%) |  |  |
 Peritoneal dialysis | 2 (2.7%) | 1 (2.3%) | 1 (3.1%) |  |  |
Hypertension | 69 (92.0%) | 38 (88.4%) | 31 (96.9%) | χ2 = 1.802 | 0.362 |
Diabetes | 5 (6.7%) | 2 (4.7%) | 3 (9.4%) | χ2 = 0.649 | 0.731 |
Age (years) | 46.49 ± 11.02 | 48.09 ± 11.79 | 44.34 ± 9.66 | t = 1.469 | 0.146 |
Duration of dialysis (years) | 8.0 (5,10) | 8 (5,10) | 9 (7,10) | Z = −1.169 | 0.242 |
BMI (kg/m2) | 22.77 ± 3.71 | 23.20 ± 3.79 | 22.19 ± 3.57 | t = 1.158 | 0.251 |
Frequency of color ultrasound | 4 (3,4) | 3 (2,4) | 4 (3,4) | Z = −1.359 | 0.174 |
Frequency of ECT | 4 (4,4) | 4 (4,4) | 4 (4,4) | Z = −0.475 | 0.635 |
Frequency of pathological examination | 4 (4,4) | 4 (4,4) | 4 (4,4) | Z = −0.454 | 0.649 |
Preoperative Hb (g/l) | 116.85 ± 18.88 | 123.19 ± 17.01 | 108.34 ± 18.12 | t = 3.635 | 0.001 |
BNP (pg/ml) | 156 (62,359) | 119 (58,265) | 249.5 (78.75,508.5) | Z = −2.105 | 0.035 |
Alb (g/l) | 42.9 (40.3,44.6) | 43.7 (42.0,45.2) | 41.4 (38.1,43.4) | Z = −2.973 | 0.003 |
Serum ALP (U/l) | 292 (144,545) | 173 (118,287) | 683.5 (354.3,974.8) | Z = −6.277 |  < 0.001 |
Serum calcium (mmol/l) | 2.45 ± 0.26 | 2.50 ± 0.26 | 2.40 ± 0.25 | t = 1.666 | 0.100 |
Serum phosphate (mmol/l) | 2.04 (1.75,2.39) | 2.05 (1.78,2.33) | 2.00 (1.71,2.51) | Z = −0.021 | 0.983 |
iPTH (pg/ml) | 2170 ± 990 | 1619 ± 668 | 2911 ± 864 | t = −7.309 |  < 0.001 |
TSH (mlu/l) | 1.59 (0.99,2.60) | 1.45 (0.99,2.68) | 1.64 (1.02,2.35) | Z = −0.107 | 0.375 |
AAC score | 3 (0,15) | 3 (0,14) | 5 (0.25,16.5) | Z = −0.708 | 0.479 |